Immune cells generally believed to aggravate chronic brain diseases have now been found to have a beneficial effect in traumatic brain injury. The normal immune function of these cells, known as microglia, is to consume cellular debris and dead neurons from nerve tissue. Until now, it was believed that microglia promoted inflammation damaging to healthy brain tissue after a traumatic injury. But a team of researchers led by Bruce Trapp, PhD, of Cleveland Clinic’s Lerner Research Institute found that microglia actually help synchronize brain firing, which protects the brain from traumatic brain injury. The findings were published in Nature Communications. “We could potentially harness the protective role of microglia to improve prognosis for patients with traumatic brain injury and delay the progression of Alzheimer disease, multiple sclerosis and stroke,” says Dr. Trapp.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
“Most of the research has focused on a pathogenic or a destructive role of microglia, and I think that’s because they remove cellular debris, and many people have confused removing cellular debris with causing the damage,” says Dr. Trapp in the video.
In the study, all the microglia in the brain were activated, and then the brain was given a lesion. “Lo and behold, the lesion was smaller and not bigger, and then we went in depth to see what the microglia were doing during this protective stage,” Dr. Trapp adds. By surrounding the neurons, the microglia enabled them to continue firing in a synchronous manner. This actually shielded the brain and reduced the size of a subsequent injury.
Dr. Trapp concludes the video with a hopeful statement about the discovery: “If we could learn how to harness the protective role of microglia, we could develop therapies that may stop the progressive neurodegenerative diseases.”
Real-world claims data and tissue culture studies set the stage for randomized clinical testing
New grant-funded investigation illustrates impact and reach of Cleveland Clinic Brain Study
How the new longitudinal investigation could become the Framingham Heart Study of brain health
Pilot findings show good patient acceptance and safety, early hints of efficacy
Study finds high prevalence of symptoms, willingness to seek treatment
Panel outlines research priorities around a promising alternative to imaging markers
Suspected factors include antithrombotic intensity, time on device, presence of thrombocytopenia
Preclinical studies will assess whether method developed for stroke recovery curbs deficits after brain injury